Study guide
22.3 Evidence-Based Dentistry & Biostatistics
NDEB Assessment of Fundamental Knowledge AFK
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the AFK & NDEB Equivalency Process 1.2 Format, Scoring, Attempts & Exam-Day Rules 1.3 Official Blueprint Weights & Study Strategy
2 Chapter 1: Head & Neck Anatomy
1.1 Osteology, Fascial Spaces & Odontogenic Spread 1.2 Cranial Nerves Relevant to Dentistry 1.3 Vascular Supply, Lymphatics, TMJ & Mastication
3 Chapter 2: Human Physiology for Dentistry
2.1 Cardiovascular & Respiratory Physiology 2.2 Renal, Endocrine & Acid-Base Physiology 2.3 Neuromuscular Physiology & Salivary Function
4 Chapter 3: Biochemistry, Nutrition & Biomaterials
3.1 Metabolism, Enzymes & Oral Biochemistry 3.2 Vitamins, Minerals & Nutritional Deficiencies 3.3 Biomaterials Science: Properties & Biocompatibility
5 Chapter 4: Oral Histology, Embryology & Growth
4.1 Tooth Development & Oral Embryology 4.2 Enamel, Dentin, Cementum, Pulp & Periodontium Histology 4.3 Craniofacial Growth & Development
6 Chapter 5: Microbiology, Immunology & Cariology
5.1 Oral Microbiome, Pathogens & Biofilms 5.2 Immunology & Hypersensitivity in the Oral Cavity 5.3 Cariology: Etiology, Progression & Prevention Science
7 Chapter 6: Dental Anatomy & Occlusion
6.1 Permanent & Primary Tooth Morphology & Roots 6.2 Eruption Sequences & FDI Numbering 6.3 Occlusion Principles & Angle Classification
8 Chapter 7: Restorative Principles & Direct Materials
7.1 Caries Diagnosis & Operative Principles 7.2 Amalgam, Composite Resin & Glass Ionomer 7.3 Adhesion, Bonding & Pulp Protection
9 Chapter 8: Indirect Restorations & Prosthodontics
8.1 Crowns, Bridges, Onlays & Preparation Design 8.2 Complete Dentures & Removable Partial Dentures 8.3 Occlusion Concepts in Prosthodontics
10 Chapter 9: Implants & Advanced Restorative
9.1 Implant Biology & Osseointegration 9.2 Implant Planning, Prosthetics & Complications 9.3 Clinical Dental Materials Selection & Failures
11 Chapter 10: Oral Medicine — Mucosal Disease
10.1 White, Red & Ulcerative Mucosal Lesions 10.2 Oral Cancer & Premalignant Conditions 10.3 Vesiculobullous & Immune-Mediated Mucosal Disease
12 Chapter 11: Oral Pathology — Hard Tissues
11.1 Cysts of the Jaws 11.2 Odontogenic Tumors 11.3 Bone Pathology & Fibro-Osseous Lesions
13 Chapter 12: Salivary Disease, Systemic Manifestations & Oral Radiology
12.1 Salivary Gland Disease 12.2 Systemic Disease Oral Manifestations 12.3 Radiation Physics & Radiographic Technique 12.4 Radiographic Anatomy, Lesions & Interpretation
14 Chapter 13: Local Anesthesia & Analgesia
13.1 Local Anesthetics & Vasoconstrictors 13.2 Injection Techniques, Failures & Complications 13.3 Analgesics, Anxiolysis & Sedation
15 Chapter 14: Systemic Pharmacology & Medical Emergencies
14.1 Antibiotics & Antimicrobials in Dentistry 14.2 Drug Interactions & the Medically Compromised Patient 14.3 Recognition of Medical Emergencies in the Dental Office 14.4 Emergency Drugs & Management Protocols
16 Chapter 15: Periodontics Foundations
15.1 Periodontal Anatomy & Pathogenesis 15.2 2017 AAP Classification of Periodontal Diseases 15.3 Periodontal Examination & Diagnosis
17 Chapter 16: Periodontal Therapy & Systemic Links
16.1 Nonsurgical Periodontal Therapy 16.2 Surgical Periodontics Basics 16.3 Periodontal–Systemic Relationships
18 Chapter 17: Endodontics
17.1 Pulp Biology & Endodontic Diagnosis 17.2 Canal Morphology & Access Preparation 17.3 Instrumentation, Irrigation & Obturation 17.4 Endodontic Emergencies, Trauma & Retreatment
19 Chapter 18: Oral Surgery, Trauma & Orofacial Pain
18.1 Exodontia Principles & Complications 18.2 Impacted Teeth & Minor Oral Surgery 18.3 Maxillofacial Trauma 18.4 Orofacial Pain, TMD & Dental Emergencies
20 Chapter 19: Orthodontics
19.1 Growth, Development & Orthodontic Diagnosis 19.2 Malocclusion Classification & Treatment Planning 19.3 Appliances, Interceptive & Comprehensive Orthodontics
21 Chapter 20: Pediatric Dentistry
20.1 Behavior Management & Primary Dentition Care 20.2 Pediatric Pulp Therapy 20.3 Pediatric Trauma & Space Management
22 Chapter 21: Geriatric & Special Needs Dentistry
21.1 Geriatric Dentistry Considerations 21.2 Special Needs Patients in Dental Practice
23 Chapter 22: Prevention & Evidence-Based Dentistry
22.1 Fluoride, Sealants & Prevention Strategies 22.2 Epidemiology, Caries Indices & Public Health 22.3 Evidence-Based Dentistry & Biostatistics
24 Chapter 23: Infection Control, Ethics & Jurisprudence
23.1 Infection Control & Sterilization 23.2 Ethics & Professionalism for Canadian Practice 23.3 Jurisprudence, Consent & Clinical Records
25 Chapter 24: Integrated Review & Exam Strategy
24.1 High-Yield Differentials Across Domains 24.2 Case Vignette Reasoning Patterns 24.3 Exam-Day Strategy & Pathway Next Steps (ACJ/NDECC)
22.3 Evidence-Based Dentistry & Biostatistics
Key Takeaways Explain This Topic AI
Evidence-based dentistry integrates best research evidence, clinical expertise, and patient values/preferences—not papers alone and not anecdote alone.
Sensitivity detects disease when present; specificity excludes disease when absent; PPV and NPV depend on prevalence as well as test accuracy.
Study designs rank from case reports through case–control and cohort studies to randomized controlled trials and systematic reviews/meta-analyses for interventional questions.
Bias (selection, information, confounding, recall, publication) systematically distorts results; random error is addressed with sample size and statistics.
P-values and confidence intervals require careful interpretation: statistical significance is not the same as clinical importance or proof of no bias.
Last updated: July 2026
22.3 Evidence-Based Dentistry & Biostatistics
Quick Answer: EBD = best evidence + clinical expertise + patient values. Frame questions with PICO , then match study design to the question. For tests, know sensitivity, specificity, PPV, NPV . For results, distinguish bias from chance, and never confuse a small p-value with automatic clinical importance.
This section is pure AFK reasoning skill: many stems describe a study or a diagnostic test and ask what it measures, what it cannot prove, or which design is strongest. Prevention claims from 22.1–22.2 are ideal material for appraisal practice.
What Evidence-Based Dentistry Is (and Is Not)
- Component Role
- Best available research evidence Systematic, preferably patient-important outcomes
- Clinical expertise Diagnosis skill, technical ability, judgment of applicability
- Patient values and circumstances Preferences, culture, costs, access, risk tolerance
Not EBD: “I always do it this way,” or “one viral post said,” or “the paper’s p < 0.05 so every patient must receive the product.”
Also not EBD: ignoring patient goals to follow a guideline blindly when comorbidities or values differ—guidelines inform, they do not replace consent.
The 5 A’s cycle (practical)
Ask a focused clinical question.
Acquire evidence (guidelines, systematic reviews, primary studies).
Appraise validity, importance, applicability.
Apply with the patient.
Assess outcomes and improve.
PICO (and PICOT)
- Letter Meaning Example
- P Patient / Population / Problem High-caries-risk children aged 6–8
- I Intervention (or exposure) School sealant program
- C Comparison No sealant / usual care
- O Outcome New DMFS over 24 months
- T Time (optional) 24 months
Diagnostic variant: P = patients suspected of disease; I = index test; C = reference standard; O = accuracy metrics.
Hierarchy of Evidence (Interventional Questions)
Higher designs better control bias when well conducted —quality still matters.
- Level (typical teaching ladder) Design Strength for therapy questions
- Highest Systematic review / meta-analysis of RCTs Synthesizes multiple trials
- High Randomized controlled trial (RCT) Randomization balances known/unknown confounders
- Moderate Cohort study (prospective/retrospective) Good for prognosis, harms, when RCT unethical/impractical
- Lower Case–control study Efficient for rare outcomes; recall/selection issues
- Lower Cross-sectional study Prevalence and associations at one time—weak for causality
- Lowest Case series / case report Hypothesis generating
- Foundation Expert opinion / pathophysiology Useful but weakest alone
Guidelines may be high impact clinically but quality varies—check whether recommendations are evidence-linked.
Matching design to question
- Question type Preferred evidence
- Therapy / prevention effectiveness RCT → systematic review of RCTs
- Harm / etiology Cohort; case–control for rare harms
- Diagnosis Cross-sectional accuracy studies vs reference standard
- Prognosis Inception cohort
- Prevalence Cross-sectional survey
AFK trap: a large case series of implant success without controls “proves” superiority of a brand—it does not.
- Diagnostic Test Metrics
- 2×2 structure
- Disease present Disease absent
- Test positive True positive (TP) False positive (FP)
- Test negative False negative (FN) True negative (TN)
- Definitions and formulas
Metric Formula Plain language When you care most
Sensitivity TP / (TP + FN) Of those with disease, % testing positive Rule out when high (SnNOut): Negative test → less likely disease
Specificity TN / (TN + FP) Of those without disease, % testing negative Rule in when high (SpPIn): Positive test → more likely disease
- PPV TP / (TP + FP) Of positive tests, % truly diseased Depends on prevalence —higher prevalence → higher PPV
- NPV TN / (TN + FN) Of negative tests, % truly non-diseased Higher when disease is rare (often)
- Accuracy (TP+TN)/all Overall correct Can mislead with imbalanced prevalence
- Likelihood ratios Combine sensitivity/specificity How much a result shifts odds Advanced but elegant
- Prevalence dependence—critical AFK concept
Sensitivity and specificity are often treated as properties of the test (in a defined population and threshold). PPV and NPV change with prevalence :
- Scenario Effect
- Screening low-risk population with imperfect specificity Many false positives → PPV drops
- Testing high-risk clinic population PPV rises for the same test
- Very rare disease Even specific tests can yield low PPV
Example narrative: A pulp vitality test with good sensitivity still needs clinical context; a positive “caries detection device” in a sealed fissure may be FP noise.
ROC thinking (recognition)
Changing the positivity threshold trades sensitivity vs specificity. ROC curves plot that tradeoff; area under curve summarizes discrimination.
- Core Biostatistics for AFK
- Types of data
- Type Examples Typical stats
- Continuous Pocket depth mm, DMFS count Means, t-tests, regression
- Binary Caries yes/no Proportions, chi-square, logistic regression
- Ordinal Pain scale 0–10 categories Nonparametric or ordinal models
- Survival Time to implant failure Kaplan–Meier, Cox models
- Central tendency and spread
- Measure Use
- Mean Symmetric continuous data
- Median Skewed data (income, some cost data)
- SD Spread around mean
- IQR Spread around median
- 95% CI Interval likely to contain the true parameter with 95% confidence under model assumptions
- Hypothesis testing language
- Concept Meaning
- Null hypothesis (H₀) Typically “no difference / no association”
- p-value Probability of data as extreme as observed if H₀ were true —not the probability H₀ is true
- α (alpha) Pre-set type I error rate (often 0.05)
- Type I error False positive: reject true H₀
- Type II error False negative: fail to reject false H₀
- Power 1 − β; probability of detecting a true effect
Clinical vs statistical significance Tiny irrelevant difference can be “significant” in huge samples; important effects can be nonsignificant if underpowered
Confidence interval pearl: a mean difference of 0.1 mm CAL with 95% CI 0.05–0.15 may be statistically significant but clinically trivial; a large effect with wide CI crossing the null is uncertain.
Relative vs absolute measures
- Measure Idea Trap
- Relative risk (RR) Risk_intervention / Risk_control “50% reduction” can hide small absolute change
- Odds ratio (OR) Odds_exposed / Odds_unexposed ≈ RR when outcomes rare; otherwise not identical
- Absolute risk reduction (ARR) Risk_control − Risk_intervention More transparent for patients
- NNT 1 / ARR Patients needed to treat for one extra good outcome
- NNH For harms Number for one extra harm
Prevention example: If sealants reduce 2-year occlusal caries from 10% to 5%, RR = 0.5 (50% relative reduction), ARR = 5%, NNT = 20.
- Bias and Validity
- Internal vs external validity
- Validity Question
- Internal Are the study’s conclusions correct for the participants studied ? (bias/confounding minimized)
External (generalizability) Do results apply to my patient / my setting?
Major bias types
Bias What goes wrong Dental example
Selection bias Who enters or remains in the study is non-comparable Clinic volunteers for a “new whitening gel” are healthier and more compliant
Information / measurement bias Exposures or outcomes measured differently across groups Examiner knows which group got sealant and scores caries more leniently
Recall bias Cases remember exposures differently than controls Oral cancer cases over-report alcohol vs controls
Interviewer bias Questioning differs by case status
Lead-time bias Early detection looks like longer survival without changing course Screening “improves survival” only by diagnosing earlier
- Length-time bias Screening finds slowly progressive disease preferentially Overestimates benefit of screening
- Publication bias Positive studies publish more readily Meta-analyses overstate effects
Confounding Third factor associated with exposure and outcome distorts effect Coffee “causes” oral cancer if smoking not controlled
- Attrition bias Differential loss to follow-up Failures drop out of implant follow-up
- Spectrum bias Diagnostic study uses extreme sick vs healthy only Overstates real-world accuracy
- Controlling confounding
- Method Notes
- Randomization Balances confounders in RCTs
- Restriction Study only non-smokers
- Matching Pair on age/sex
- Stratification / multivariable analysis Statistical adjustment—residual confounding possible
- Appraising a Prevention Claim (Worked Pattern)
- Claim: “Product X toothpaste cuts cavities 40%.”
PICO: Who? vs what? measured how?
Design: RCT of children? industry-funded?
Outcomes: DMFS increments? patient-important?
Absolute numbers: 40% of what baseline? NNT?
Bias: blinding of examiners? attrition?
Applicability: fluoride background, diet, Canadian setting?
Harms/cost: fluorosis, price, adherence?
Patient values: taste, cost, preferences.
Ethics of Evidence Use
Do not overstate certainty to sell procedures.
Disclose material alternatives (including monitoring/prevention).
Research participation needs consent and REB oversight (jurisprudence crossover).
Industry relationships require transparent appraisal.
- Rapid review list
- EBD triad: evidence + expertise + patient values
- PICO structures searchable questions
- Therapy: prefer well-done RCTs and systematic reviews
- Sensitivity/specificity vs PPV/NPV (prevalence matters for PPV/NPV)
- SnNOut / SpPIn mnemonics
- p-value ≠ probability the null is true; ≠ clinical importance
- ARR and NNT communicate absolute benefit
- Selection, information, confounding, recall, publication, lead-time, length-time biases
- Internal validity first, then external applicability
Mastery of Chapters 22.1–22.3 means you can deliver fluoride and sealants correctly, speak the language of population oral health and DMFT, and critically appraise the evidence behind any prevention or treatment claim—the full prevention and EBD slice of the AFK blueprint.